Your browser doesn't support javascript.
loading
Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
Alharbi, Ebtisam; Gadiya, Yojana; Henderson, David; Zaliani, Andrea; Delfin-Rossaro, Alejandra; Cambon-Thomsen, Anne; Kohler, Manfred; Witt, Gesa; Welter, Danielle; Juty, Nick; Jay, Caroline; Engkvist, Ola; Goble, Carole; Reilly, Dorothy S; Satagopam, Venkata; Ioannidis, Vassilios; Gu, Wei; Gribbon, Philip.
Afiliação
  • Alharbi E; Department of Computer Science, The University of Manchester, Oxford Road, Manchester, UK; College of Computer and Information Systems, Umm Al-Qura University, Mecca, Saudi Arabia.
  • Gadiya Y; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525 Hamburg, and Theodor Stern Kai 7, 60590 Frankfurt, Germany; Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Theodor Stern Kai 7, 60590 Frankfurt, Germany.
  • Henderson D; Bayer AG, Research & Development, Pharmaceuticals, Müllerstrasse 178, 13353 Berlin, Germany.
  • Zaliani A; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525 Hamburg, and Theodor Stern Kai 7, 60590 Frankfurt, Germany; Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Theodor Stern Kai 7, 60590 Frankfurt, Germany.
  • Delfin-Rossaro A; CERPOP, UMR 1295, INSERM, Université Paul Sabatier -Toulouse III, France.
  • Cambon-Thomsen A; CERPOP, UMR 1295, INSERM, Université Paul Sabatier -Toulouse III, France.
  • Kohler M; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525 Hamburg, and Theodor Stern Kai 7, 60590 Frankfurt, Germany; Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Theodor Stern Kai 7, 60590 Frankfurt, Germany.
  • Witt G; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525 Hamburg, and Theodor Stern Kai 7, 60590 Frankfurt, Germany; Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Theodor Stern Kai 7, 60590 Frankfurt, Germany.
  • Welter D; Luxembourg Centre for Systems Biomedicine, ELIXIR Luxembourg, University of Luxembourg, L-4367 Belval, Luxembourg.
  • Juty N; Department of Computer Science, The University of Manchester, Oxford Road, Manchester, UK.
  • Jay C; Department of Computer Science, The University of Manchester, Oxford Road, Manchester, UK.
  • Engkvist O; Discovery Sciences, R&D, AstraZeneca, SE-43183 Mölndal, Sweden.
  • Goble C; Department of Computer Science, The University of Manchester, Oxford Road, Manchester, UK.
  • Reilly DS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Satagopam V; Luxembourg Centre for Systems Biomedicine, ELIXIR Luxembourg, University of Luxembourg, L-4367 Belval, Luxembourg.
  • Ioannidis V; SIB Swiss Institute of Bioinformatics, Quartier Sorge - Batiment Amphipole, 1015 Lausanne, Switzerland. Electronic address: Vassilios.Ioannidis@sib.swiss.
  • Gu W; Luxembourg Centre for Systems Biomedicine, ELIXIR Luxembourg, University of Luxembourg, L-4367 Belval, Luxembourg. Electronic address: Wei.Gu@uni.lu.
  • Gribbon P; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525 Hamburg, and Theodor Stern Kai 7, 60590 Frankfurt, Germany; Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Theodor Stern Kai 7, 60590 Frankfurt, Germany. Electronic address:
Drug Discov Today ; 27(8): 2080-2085, 2022 08.
Article em En | MEDLINE | ID: mdl-35595012

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Descoberta de Drogas Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Descoberta de Drogas Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article